SecBot SecBot
SECBOTREPLAY Home › Report › CGON

CGON · CG Oncology appointed Jim DeTore as Chief Financial Officer, effective…

CG Oncology, Inc. · 8-K filed Apr 13, 2026 at 08:30 ET

At the news

NEUTRALIMPACT 3/10

8-K filed Apr 13, 2026 at 08:30 ET

CG Oncology appointed Jim DeTore as Chief Financial Officer, effective April 13, 2026. The appointment follows his interim role since November 2025 and includes a formal employment agreement with a $520,000 annual base salary and $5 million in initial equity awards.

  • Jim DeTore was formally appointed Chief Financial Officer effective April 13, 2026
  • DeTore had been serving as Interim Principal Financial and Accounting Officer since November 2025
  • He receives a $520,000 annual base salary and is eligible for a 45% target annual bonus
  • He received an initial stock option grant valued at $4 million and a performance stock unit award valued at $1 million

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access